Endothelial-mesenchymal interactions in vitro reveal molecular mechanisms of smooth muscle/pericyte differentiation

Stem Cells and Development

Volumn 13, Issue 5, 2004, Pages 509-520

  Ding, Rubai ^a,c   Darland, Diane C ^a   Parmacek, Michael S ^b   D'Amore, Patricia A ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; MUSCLE PROTEIN; PROTEIN; PROTEIN CARG; PROTEIN SMOOTH MUSCLE 22ALPHA; PROTEIN TCE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; MESENCHYME CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERICYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; REPORTER GENE; RETINA BLOOD VESSEL; SMOOTH MUSCLE; UPREGULATION;

ANIMALS; BLOTTING, NORTHERN; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; IMMUNOHISTOCHEMISTRY; LUCIFERASES; MESODERM; MICE; MICE, TRANSGENIC; MICROCIRCULATION; MICROSCOPY, CONFOCAL; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; PLASMIDS; PROMOTER REGIONS (GENETICS); RETINA; TIME FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 8144221439     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2004.13.509     Document Type: Article

References (39)

1. Benjamin LE, I Hemo and E Keshet. (1998). A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125:1591-1598.
2. Hirschi K, SA Rohovsky and PA D'Amore. (1998). PDGF, TGF-β and heterotypic cell-cell interactions mediate the recruitment and differentiation of 10T1/2 cells to a smooth muscle cell fate. J Cell Biol 141:805-814.
3. Darland DC and PA D'Amore. (1999). Blood vessel maturation: vascular development come of age. J Clin Invest 103:157-158.
4. Risau W. (1995). Differentiation of endothelium. FASEB J 9:926-933.
5. Hellström M, M Kalen, P Lindahl, A Abramsson and C Betsholtz. (1999). Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126:3047-3055.
6. Lees-Miller JP, DH Heeley, LB Smillie and CM Kay. (1987). Isolation and characterization of an abundant and novel 22-kDa protein(SM22α) from chicken gizzard smooth muscle. J Biol Chem 262:2988-2993.
7. Li L, JM Miano, P Cserjesi and EN Olson. (1995). SM22α, a marker of adult smooth muscle, is expressed in multiple muogenic lineages during embryogenesis. Circ Res 78:188-195.
8. Li L, MM Joseph, B Mercer and E Olson, N. (1996). Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol 132:849-859.
9. Moessler H, M Mericskay, Z Li, S Nagl, D Paulin and JV Small. (1996). The SM22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development 122:2415-2425.
10. Hautmann MB, CS Madsen and GK Owens. (1997). A transforming growth factor-β (TGF-beta) control element drives TGF-β-induced stimulation of smooth muscle alpha-actin gene expression in concert with 2 CArG elements. J Biol Chem 272:10948-10956.
11. Solway J, J Seltzer, FF Samaha, S Kim, LE Alger, Q Nui, EE Morrisey, HS Ip and MS Parmacek. (1995). Structure and expression of a smooth muscle cell-specific gene, SM22α. J Biol Chem 270:13460-13469.
12. Darland DC and PA D'Amore. (2001). TGFβ is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis 4:11-20.
13. Kim S, H Lin, E Barr, L Chu, JM Leiden, and MS Parmacek (1997a). Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo. J Clin Invest 100(5):1006-1014.
14. Metzger JM, MS Parmacek, E Barr, K Pasyk, WI Lin, KL Cochrane, LJ Field, and JM Leiden. (1993). Skeletal troponin C reduces contractile sensitivity to acidosis in cardiac myocytes from transgenic mice. Proc Natl Acad Sci USA 90:9036-9040.
15. Kim S, HS IP, M Lu, C Clendenin and MS Parmacek. (1997b). A serum response factor-dependent transcriptional regulatory program identified distinct smooth muscle cell sublineages. Mol Cell Biol 17:2266-2278.
16. Blanks JC and LV Johnson. (1983). Selective lectin binding of the developing mouse retina. J Comp Neurol 221:31-41.
17. Abramsson A, P Lindblom and C Betsholtz. (2003). Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 112:1142-1151.
18. Antonelli-Orlidge A, KB Saunders, SR Smith and PA D'Amore. (1989). An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86:4544-4548.
19. Sato Y and DB Rifkin. (1989). Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol 109:309-315.
20. Orlidge A and PA D'Amore. (1987). Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 105:1455-1462.
21. Darland DC, LJ Massingham, SR Smith, E Piek, M Saint-Geniez and PA D'Amore. (2003). Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol 264:275-288.
22. Munger J, J Harpel, P Gleizes, R Mazzieri, I Nunes and D Rifkin. (1997). Latent transforming growth factor-β: Structural features and mechanisms of activation. Kidney International 51(5):1376-1382.
23. Huang SS, P O'Grady and JS Huang. (1988). Human transforming growth factor β-α2-macroglobulin complex is a latent form of transforming growth factor β. J Biol Chem 263:1535-1541.
24. Sato Y, R Tsuboi, R Lyons, H Moses and DB Rifkin. (1990). Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol 111:757-763.
25. Owens GK. (1998). Molecular control of vascular smooth muscle cell differentiation. Acta Physiol Scand 164:623-635.
26. Chang Y-F, J Wei, X Liu, Y-H Chen, MD Layne and S-F Yet. (2003). Identification of a CArG-independent region of the cysteine-rich protein 2 promoter that directs expression in the developing vasculature. Am J Physiol Heart Circ Physiol 285:H1675-H1683.
27. Miano JM. (2003). Serum response factor: toggling between disparate programs of gene expression. J Mol Cel Cardiol 35:577-593.
28. Browning CL, DE Culberson, IV Aragon, RA Fillmore, JD Croissant, RJ Schwartz and WE Zimmer. (1998). The developmentally regulated expression of serum response factor plays a key role in the control of smooth muscle-specific genes. Develop Biol 194:18-37.
29. Hirschi KK, L Lai, NS Belaguli, DA Dean, RJ Schwartz and WE Zimmer. (2002). Transforming growth factor-β induction of smooth muscle cell phenotype requires transcriptional and post-transcriptional control of serum response factor. J Biol Chem 277:6287-6295.
30. Lilly B, EN Olson and MC Beckerle. (2001) Identification of a CArG box-dependent enhancer within the cysteine-rich protein 1 gene that directs expression in arterial but not venous or visceral smooth muscle cells. Develop Biol 240:531-547.
31. Du KL, SI Hon, J Li, M Chen, F Dandre, W Yu, MM Lu, GK Owens and MS Parmacek. (2003). Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol 23:2425-2437.
32. Adam PJ, CP Regan, MB Hautmann and GK Owens. (2000). Positive- and negative-acting Krüppel-like transcription factors bind a transforming growth factor β control element required for expression of the smooth muscle cell differentiation marker SM22α in vivo. J Biol Chem 275:37798-37806.
33. Kumar MS and GK Owens. (1997). Combinatorial control of smooth muscle-specific gene expression. Aterioscler Thromb Vasc Biol 23:737-747.
34. Kim S, H Lin, E Barr, L Chu, JM Leiden and MS Parmacek. (1997). Transcriptinal targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo. J Clin Invest 100:1006.
35. Xu R, Y-S Ho, RP Ritchie and L Li. (2003). Human SM22α BAC encompasses regulatory sequences for expression in vascular and visceral smooth muscles at fetal and adult stages. Am J Physiol Heart Circ Physiol 284:H1398-H1407.
36. Li DY, LK Sorensen, BS Brooke, LD Urness, EC Davis, DG Taylor, BB Boak and DP Wendel. (1999). Defective angiogenesis in mice lacking endoglin. Science 284:1534-1537.
37. Torsney E, R Charlton, AG Diamond, J Burn, JV Soames and HM Arthur. (2003). Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality. Circulation 107:1653-1657.
38. Hirschi KK, JM Burt, KD Hirschi and C Dai. (2003). Gap junction communication mediates TGFβ activation and endothelial-induced mural cell differentiation. Circ Res 93:429-437.
39. Hirschi KK, SA Rohovsky, LH Beck, SR Smith and PA D'Amore. (1999). Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ Res 84:298-305.